Following fields are empty!
Welcome to the University of Turku Journal Guide
The Journal Guide gives you peace of mind when selecting journals. If you are a researcher from the University of Turku you can look up your favorite journals or search and filter to get to a selection of journals that match your research. Select a funder to see whether the journals are compliant or not, and check the filter ‘Journals with agreements’ to limit the list to journals for which the APCs are fully or partially waived.
Case Reports in Allergy
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Case Reports in Anesthesiology
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELib-konsortion sopimus Wileyn kanssa mahdollistaa vastaaville kirjoittajille artikkeleiden julkaisemisen avoimena Wileyn full OA- ja hybridilehdissä sopimuskaudella 2025–2026. Avoimia artikkeleita voidaan julkaista rajoitettu määrä. Full OA -lehtien ja hybridilehtien artikkeleille on molemmille oma kiintiönsä.FinELib consortium’s agreement with Wiley enables the corresponding authors to publish their articles open access in Wiley’s Full OA and hybrid journals during the agreement term 2025–2026. The agreement includes a limited number of articles. There is a separate quota for both Full OA and hybrid journal articles.
- Ohjeita julkaisemiseen FinELibin sivuilla: Artikkelin julkaiseminen avoimena Wileyn lehdissä
- Instructions on publishing on FinELib's pages: Open Access Publishing in Wiley Journals
- AI guidelines for researchers: Using AI Tools in Your Research
Case Reports in Cardiology
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELib-konsortion sopimus Wileyn kanssa mahdollistaa vastaaville kirjoittajille artikkeleiden julkaisemisen avoimena Wileyn full OA- ja hybridilehdissä sopimuskaudella 2025–2026. Avoimia artikkeleita voidaan julkaista rajoitettu määrä. Full OA -lehtien ja hybridilehtien artikkeleille on molemmille oma kiintiönsä.FinELib consortium’s agreement with Wiley enables the corresponding authors to publish their articles open access in Wiley’s Full OA and hybrid journals during the agreement term 2025–2026. The agreement includes a limited number of articles. There is a separate quota for both Full OA and hybrid journal articles.
- Ohjeita julkaisemiseen FinELibin sivuilla: Artikkelin julkaiseminen avoimena Wileyn lehdissä
- Instructions on publishing on FinELib's pages: Open Access Publishing in Wiley Journals
- AI guidelines for researchers: Using AI Tools in Your Research
Case Reports in Clinical Medicine
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Case Reports in Clinical Pathology
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Case Reports in Clinical Practice
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Case Reports in Critical Care
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELib-konsortion sopimus Wileyn kanssa mahdollistaa vastaaville kirjoittajille artikkeleiden julkaisemisen avoimena Wileyn full OA- ja hybridilehdissä sopimuskaudella 2025–2026. Avoimia artikkeleita voidaan julkaista rajoitettu määrä. Full OA -lehtien ja hybridilehtien artikkeleille on molemmille oma kiintiönsä.FinELib consortium’s agreement with Wiley enables the corresponding authors to publish their articles open access in Wiley’s Full OA and hybrid journals during the agreement term 2025–2026. The agreement includes a limited number of articles. There is a separate quota for both Full OA and hybrid journal articles.
- Ohjeita julkaisemiseen FinELibin sivuilla: Artikkelin julkaiseminen avoimena Wileyn lehdissä
- Instructions on publishing on FinELib's pages: Open Access Publishing in Wiley Journals
- AI guidelines for researchers: Using AI Tools in Your Research
Case Reports in Dentistry
publishes case reports and case series in all areas of dentistry, including periodontal diseases, dental implants, oral pathology, as well as oral and maxillofacial surgery.
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELib-konsortion sopimus Wileyn kanssa mahdollistaa vastaaville kirjoittajille artikkeleiden julkaisemisen avoimena Wileyn full OA- ja hybridilehdissä sopimuskaudella 2025–2026. Avoimia artikkeleita voidaan julkaista rajoitettu määrä. Full OA -lehtien ja hybridilehtien artikkeleille on molemmille oma kiintiönsä.FinELib consortium’s agreement with Wiley enables the corresponding authors to publish their articles open access in Wiley’s Full OA and hybrid journals during the agreement term 2025–2026. The agreement includes a limited number of articles. There is a separate quota for both Full OA and hybrid journal articles.
- Ohjeita julkaisemiseen FinELibin sivuilla: Artikkelin julkaiseminen avoimena Wileyn lehdissä
- Instructions on publishing on FinELib's pages: Open Access Publishing in Wiley Journals
- AI guidelines for researchers: Using AI Tools in Your Research
Case Reports in Dermatological Medicine
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELib-konsortion sopimus Wileyn kanssa mahdollistaa vastaaville kirjoittajille artikkeleiden julkaisemisen avoimena Wileyn full OA- ja hybridilehdissä sopimuskaudella 2025–2026. Avoimia artikkeleita voidaan julkaista rajoitettu määrä. Full OA -lehtien ja hybridilehtien artikkeleille on molemmille oma kiintiönsä.FinELib consortium’s agreement with Wiley enables the corresponding authors to publish their articles open access in Wiley’s Full OA and hybrid journals during the agreement term 2025–2026. The agreement includes a limited number of articles. There is a separate quota for both Full OA and hybrid journal articles.
- Ohjeita julkaisemiseen FinELibin sivuilla: Artikkelin julkaiseminen avoimena Wileyn lehdissä
- Instructions on publishing on FinELib's pages: Open Access Publishing in Wiley Journals
- AI guidelines for researchers: Using AI Tools in Your Research
Case Reports in Dermatology
Case Reports in Dermatology is a peer-reviewed, open-access journal that publishes original case studies covering the entire spectrum of dermatology, including prevention, diagnosis, treatment, toxicities of therapy, supportive care, quality-of-life, and survivorship issues. The journal will also accept case reports related to the use of novel technologies, both in the area of diagnosis and treatment. Supplementary material is welcomed and free of charge. In this forum, clinicians and researchers communicate their observations to the broadest possible audience in the community.
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
List Price
List Price
Case Reports in Emergency Medicine
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Case Reports in Emergency Surgery and Trauma
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Case Reports in Endocrinology
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELib-konsortion sopimus Wileyn kanssa mahdollistaa vastaaville kirjoittajille artikkeleiden julkaisemisen avoimena Wileyn full OA- ja hybridilehdissä sopimuskaudella 2025–2026. Avoimia artikkeleita voidaan julkaista rajoitettu määrä. Full OA -lehtien ja hybridilehtien artikkeleille on molemmille oma kiintiönsä.FinELib consortium’s agreement with Wiley enables the corresponding authors to publish their articles open access in Wiley’s Full OA and hybrid journals during the agreement term 2025–2026. The agreement includes a limited number of articles. There is a separate quota for both Full OA and hybrid journal articles.
- Ohjeita julkaisemiseen FinELibin sivuilla: Artikkelin julkaiseminen avoimena Wileyn lehdissä
- Instructions on publishing on FinELib's pages: Open Access Publishing in Wiley Journals
- AI guidelines for researchers: Using AI Tools in Your Research
Case Reports in Gastroenterology
Case Reports in Gastroenterology is a peer-reviewed, open-access journal that publishes original case reports covering the entire spectrum of gastroenterology. The journal will also accept case reports related to the use of novel technologies, both in the area of diagnosis and treatment. Supplementary material is welcomed and free of charge. The reports are organized according to the classification used by the American Gastroenterological Association Institute; it will be possible to search across the entire growing collection of case reports with universally used terms, further facilitating the retrieval of specific information. In this forum, clinicians and researchers communicate their observations to the broadest possible audience in the community.
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
List Price
List Price
Case Reports in Gastrointestinal Medicine
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELib-konsortion sopimus Wileyn kanssa mahdollistaa vastaaville kirjoittajille artikkeleiden julkaisemisen avoimena Wileyn full OA- ja hybridilehdissä sopimuskaudella 2025–2026. Avoimia artikkeleita voidaan julkaista rajoitettu määrä. Full OA -lehtien ja hybridilehtien artikkeleille on molemmille oma kiintiönsä.FinELib consortium’s agreement with Wiley enables the corresponding authors to publish their articles open access in Wiley’s Full OA and hybrid journals during the agreement term 2025–2026. The agreement includes a limited number of articles. There is a separate quota for both Full OA and hybrid journal articles.
- Ohjeita julkaisemiseen FinELibin sivuilla: Artikkelin julkaiseminen avoimena Wileyn lehdissä
- Instructions on publishing on FinELib's pages: Open Access Publishing in Wiley Journals
- AI guidelines for researchers: Using AI Tools in Your Research
Case Reports in Genetics
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELib-konsortion sopimus Wileyn kanssa mahdollistaa vastaaville kirjoittajille artikkeleiden julkaisemisen avoimena Wileyn full OA- ja hybridilehdissä sopimuskaudella 2025–2026. Avoimia artikkeleita voidaan julkaista rajoitettu määrä. Full OA -lehtien ja hybridilehtien artikkeleille on molemmille oma kiintiönsä.FinELib consortium’s agreement with Wiley enables the corresponding authors to publish their articles open access in Wiley’s Full OA and hybrid journals during the agreement term 2025–2026. The agreement includes a limited number of articles. There is a separate quota for both Full OA and hybrid journal articles.
- Ohjeita julkaisemiseen FinELibin sivuilla: Artikkelin julkaiseminen avoimena Wileyn lehdissä
- Instructions on publishing on FinELib's pages: Open Access Publishing in Wiley Journals
- AI guidelines for researchers: Using AI Tools in Your Research
Case Reports in Hematology
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELib-konsortion sopimus Wileyn kanssa mahdollistaa vastaaville kirjoittajille artikkeleiden julkaisemisen avoimena Wileyn full OA- ja hybridilehdissä sopimuskaudella 2025–2026. Avoimia artikkeleita voidaan julkaista rajoitettu määrä. Full OA -lehtien ja hybridilehtien artikkeleille on molemmille oma kiintiönsä.FinELib consortium’s agreement with Wiley enables the corresponding authors to publish their articles open access in Wiley’s Full OA and hybrid journals during the agreement term 2025–2026. The agreement includes a limited number of articles. There is a separate quota for both Full OA and hybrid journal articles.
- Ohjeita julkaisemiseen FinELibin sivuilla: Artikkelin julkaiseminen avoimena Wileyn lehdissä
- Instructions on publishing on FinELib's pages: Open Access Publishing in Wiley Journals
- AI guidelines for researchers: Using AI Tools in Your Research
Case Reports in Hepatology
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELib-konsortion sopimus Wileyn kanssa mahdollistaa vastaaville kirjoittajille artikkeleiden julkaisemisen avoimena Wileyn full OA- ja hybridilehdissä sopimuskaudella 2025–2026. Avoimia artikkeleita voidaan julkaista rajoitettu määrä. Full OA -lehtien ja hybridilehtien artikkeleille on molemmille oma kiintiönsä.FinELib consortium’s agreement with Wiley enables the corresponding authors to publish their articles open access in Wiley’s Full OA and hybrid journals during the agreement term 2025–2026. The agreement includes a limited number of articles. There is a separate quota for both Full OA and hybrid journal articles.
- Ohjeita julkaisemiseen FinELibin sivuilla: Artikkelin julkaiseminen avoimena Wileyn lehdissä
- Instructions on publishing on FinELib's pages: Open Access Publishing in Wiley Journals
- AI guidelines for researchers: Using AI Tools in Your Research
Case Reports in Immunology
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELib-konsortion sopimus Wileyn kanssa mahdollistaa vastaaville kirjoittajille artikkeleiden julkaisemisen avoimena Wileyn full OA- ja hybridilehdissä sopimuskaudella 2025–2026. Avoimia artikkeleita voidaan julkaista rajoitettu määrä. Full OA -lehtien ja hybridilehtien artikkeleille on molemmille oma kiintiönsä.FinELib consortium’s agreement with Wiley enables the corresponding authors to publish their articles open access in Wiley’s Full OA and hybrid journals during the agreement term 2025–2026. The agreement includes a limited number of articles. There is a separate quota for both Full OA and hybrid journal articles.
- Ohjeita julkaisemiseen FinELibin sivuilla: Artikkelin julkaiseminen avoimena Wileyn lehdissä
- Instructions on publishing on FinELib's pages: Open Access Publishing in Wiley Journals
- AI guidelines for researchers: Using AI Tools in Your Research
Case Reports in Infectious Diseases
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELib-konsortion sopimus Wileyn kanssa mahdollistaa vastaaville kirjoittajille artikkeleiden julkaisemisen avoimena Wileyn full OA- ja hybridilehdissä sopimuskaudella 2025–2026. Avoimia artikkeleita voidaan julkaista rajoitettu määrä. Full OA -lehtien ja hybridilehtien artikkeleille on molemmille oma kiintiönsä.FinELib consortium’s agreement with Wiley enables the corresponding authors to publish their articles open access in Wiley’s Full OA and hybrid journals during the agreement term 2025–2026. The agreement includes a limited number of articles. There is a separate quota for both Full OA and hybrid journal articles.
- Ohjeita julkaisemiseen FinELibin sivuilla: Artikkelin julkaiseminen avoimena Wileyn lehdissä
- Instructions on publishing on FinELib's pages: Open Access Publishing in Wiley Journals
- AI guidelines for researchers: Using AI Tools in Your Research